Navigation Links
Gary Wenzel Named President TBWA\WorldHealth

NEW YORK, Nov. 12 /PRNewswire-FirstCall/ -- TBWA Worldwide today announced the appointment of Gary Wenzel as President, TBWA\WorldHealth. Wenzel was previously Chief Operating Officer of TBWA\Hakuhodo in Tokyo. He will be based in New York, and report to Tom Carroll, President & CEO, TBWA Worldwide. TBWA\WorldHealth New York also announced today the appointment of Steve Pashkoff as Executive Creative Director.

Formed in 2002, TBWA\WorldHealth integrates the comprehensive expertise of professional pharmaceutical and healthcare agencies with TBWA's approach to driving growth built on the practices of Disruption and Media Arts. TBWA\WorldHealth is headquartered in New York and has international hub offices in London, Paris, Mexico City and Hamburg, along with local offices throughout Europe and Asia. It services globally or regionally brands from Pfizer, Bristol-Myers Squibb, Roche, GlaxoSmithKline, Johnson & Johnson, and Schering-Plough, among others.

"With the diversity in healthcare offerings and differences in regulatory, more clients are coming to TBWA to help them build and manage their brands globally. Gary's experience in leading global clients like Nissan, as well as managing one of our key international offices makes him uniquely qualified to take over a very important global role for us," said Carroll.

Wenzel joined TBWA in 2001 as President & CEO of \G1 Worldwide, a joint venture between TBWA Worldwide and Hakuhodo, to manage and develop the Nissan business globally, and ultimately became a founding partner in TBWA\Hakuhodo in 2006, assuming the role of Chief Operating Officer for the agency that handles accounts such as Nissan, Apple, adidas and Haagen-Dazs.

Wenzel is a Stanford graduate and has an MBA from UCLA. Wenzel has extensive experience in all facets of marketing and advertising. At RPA in the US, before joining TBWA, he was Director of Account Services, which included research and account planning groups for all of the agencies accounts and prior to RPA, he did a three-year stint with Levi Strauss & Co.

Wenzel's experience spans a wide range of other blue chip global and American brands including Procter & Gamble, McDonald's, Kellogg's, Microsoft, Philips Electronics, ARCO, ampm, and various telecom and Internet-related companies.

"We have worked very hard to find the best talent in the business to bolster the agency's healthcare offering. Steve brings with him 28 years of advertising experience, the last 12 of which have been solely devoted to pharmaceutical healthcare. His appointment puts in place the talent needed to grow and better serve our clients," said Mark Figliulo, Chairman and Chief Creative Officer, TBWA\Chiat\Day New York.

Prior to joining TBWA, Steve was the Chief Creative Officer for Evologue, a CommonHealth Company. There he helped AZ launch Symbicort, created the first ever compliance only ad campaign for Toprol-XL, as well as created award winning communications for Novartis Vaccines, Bayer Women's Health, and Reckitt-Benckiser Inc.

While at Saatchi Healthcare, Steve re-launched Prilosec, creating The Purple Pill and later building upon Prilosec's equity, created The New Purple Pill for Nexium. His work on those two brands was instrumental in AZ awarding Crestor to Saatchi where Steve created the Mandy Patinkin campaign.

Steve began his career at Grey working on P&G, Playtex, and Swift Premium, and Clairol brands. Later working on Bristol-Myers Squibb brands like Keri Lotion, Ban and Excedrin. A New Yorker, born and raised, Steve currently lives in Brooklyn with his wife and new baby daughter.

About TBWA Worldwide

TBWA Worldwide ( creates Disruptive ideas for global clients, including ABSOLUT, adidas, Apple, Beiersdorf, GSK, Henkel, Infiniti, Mars, McDonald's, Michelin, Nissan, Pernod Ricard, Samsonite, Standard Chartered Bank, Singapore Airlines, Sony PlayStation and Visa. TBWA is one of the fastest-growing networks in the Top-Ten worldwide advertising agencies, and was named 2008 Global Agency of the Year by Advertising Age and Adweek, magazines. Fast Company Magazine placed TBWA 24th on its 2009 list of "The World's 50 Most Innovative Companies." TBWA has 267 offices in 77 countries, and approximately 11,000 employees worldwide.

TBWA is part of Omnicom Group Inc. (NYSE: OMC) (, a leading global marketing and corporate communications company. Omnicom's branded networks and numerous specialty firms provide advertising, strategic media planning and buying, digital and interactive marketing, direct and promotional marketing, public relations and other specialty communications services to over 5,000 clients in more than 100 countries.


Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. eCardio Named One of Houstons Fastest Growing Technology Companies at the 2009 Houston Business Journal FastTech 50 Awards Luncheon
2. Young Innovations, Inc. is Named to Forbes List of Americas 200 Best Small Companies
3. Csuy Named Senior Vice President/General Merchandise Manager
4. Advanced Health Media Named to Deloittes 2009 Technology Fast 500(TM)
5. Cantel Medical Named to the Forbes 2009 List of the 200 Best Small Companies in America
6. BD Ranked in the Top 100 Greenest Big Companies by Newsweek; Named Again to Dow Jones Sustainability World and North America Indexes
7. Oppenheimers Investment Bank Continues Expansion -- Lance Alstodt Named Managing Director - Healthcare
8. EMD Serono, Inc. Named as a Top Employer by Science Magazine
9. Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009
10. Cell Therapeutics and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone
11. Ikaria(R) Named Private Company of the Year by New Jersey Technology Council
Post Your Comments:
(Date:11/26/2015)... Bajos, November 26, 2015 Un ... de Bremachlorin para el cáncer avanzado.   ... la terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Cancer Research . --> Clinical Cancer Research ...
(Date:11/26/2015)... , November 26, 2015 --> ... to use SyMRI to find optimal contrast weighting of MRI ... metastases, and has signed a research agreement with SyntheticMR in ... hospital. Using SyMRI, it is possible to generate multiple contrast ... after the patient has left, thus making it possible to ...
(Date:11/26/2015)... November 26, 2015 ... the "2016 Future Horizons and Growth ... Testing Market: Supplier Shares, Country Segment Forecasts, ... their offering. --> ) ... "2016 Future Horizons and Growth Strategies in ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... ... Consultants has prided itself for not only fulfilling the needs of advisers and ... at an affordable price and providing top-tier customer service. However, there's always room ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... CBD ... Accreditation of Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography ... CAAHEP accredited colleges, as only one of twelve colleges and universities in the state ...
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... ... California Medical Associates, Inc. and Dr. Tucker Bierbaum with Emergency Medicine at ... They observed that both STEMI and Sepsis conditions present in similar ways and require ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... software Q-Suite, announces the incorporation of Asterisk 11 LTS (Long Term Support) into ... Asterisk 11 LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk that ...
(Date:11/26/2015)... NV (PRWEB) , ... November 26, 2015 , ... Inevitably ... strategy. Many customers choose to buy during the Black Friday and Cyber Monday ... Shoppers don’t need to search the Internet high and low to find the best ...
Breaking Medicine News(10 mins):